Ronquest N, La L, Nag A. Characterizing patients with IBD in Japan: epidemiology, symptoms, treatment pathways and humanistic burden. Poster presented at the 2020 Virtual Japan Digestive Disease Week Conference; November 2020.
Ronquest N, La L, Nag A. The economic burden of inflammatory bowel disease in Japan: results from a systematic literature review. Poster presented at the 2020 Virtual Japan Digestive Disease Week Conference; November 2020.
Ling W, Nadipelli VR, Ronquest NR, Aldridge A, Solem CT, Peiper N, Learned S, Heidbreder C. How long should pharmacotherapy last for the treatment of opioid use disorder? Results from a 12-month observational study. Poster presented at the 2019 College on Problems of Drug Dependence 81st Annual Scientific Meeting; June 15, 2019. San Antonio, TX.
Ling W, Nadipelli V, Ronquest N, Aldridge A, Solem C, Learned S, Heidbreder C, Peiper N. Recovery from OUD post monthly buprenorphine-XR treatment: 12-month longitudinal outcomes. Poster presented at the 2019 American Society of Addiction Medicine (ASAM) 50th Annual Conference; April 5, 2019. Orlando, FL.
Ling W, Nadipelli VR, Solem CT, Ronquest NA, Yeh Y, Heidbrede C, Learned SM. Impact of RBP-6000 (depot buprenorphine) on patient-reported outcomes: a long-term study. Poster presented at the American Society of Addiction Medicine 49th Annual Conference; April 13, 2018. San Diego, CA.
Nadipelli VR, Solem CT, Ronquest NA, Yeh Y, Heidbreder C, Learned SM, Mehra V. Impact of RBP-6000 on patient-reported outcomes in patients with opioid use disorder: results of a randomized, placebo-controlled, phase 3 study. Poster presented at the 41st Association of Medical Education and Research in Substance Abuse (AMERSA) Annual National Conference; November 2017. Washington, DC. doi: 10.1080/08897077.2018.1441944
Tkacz J, Brady B, Nadipelli V, Volpicelli J, Ronquest N, Un H, Ruetsch C. Opioid use disorder population: who is at risk of medication assisted treatment non-adherence? Poster presented at the 2016 AATOD Conference; October 31, 2016. Baltimore, MD.
Wollschlaeger BA, Montejano LB, Wilson TM, Ronquest N, Nadipelli VR. How do patients diagnosed with opioid use disorders compare to the overall US population of individuals with drug use disorder? Poster presented at the 29th Annual U.S. Psychiatric & Mental Health Congress; October 2016. San Antonio, TX.
Wollschlaeger B, Montejano L, Willson T, Ronquest N, Juneau P, Nadipelli V. Factors associated with buperhorphine medication assisted treatment adherence in patients diagnosed with opioid use disorder. Poster presented at the 29th Annual U.S. Psychiatric & Mental Health Congress; October 2016. San Antonio, TX.
Boscarino JA, Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH. A 10 year retrospective study of opioid overdoses among patients in a large integrated healthcare system. Poster presented at the 2016 International Conference on Opioids Conference; June 2016. Boston, MA.
Akashi-Ronquest N. The effect of marriage, divorce, and remarriage on children's academic performance. Poster presented at the Employee Training and Development Lecture; September 2007. Previously presented at the Western Economics Association Meeting.